Total Payments
$251.32
2024 Payments
$21.47
Companies
7
Transactions
15
Medicare Patients
1,574
Medicare Billing
$61,125
Payment Breakdown by Category
Food & Beverage$251.32 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $251.32 | 15 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $71.59 | 4 | $0 (2023) |
| GlaxoSmithKline, LLC. | $63.51 | 4 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $34.96 | 2 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $27.03 | 2 | $0 (2023) |
| PFIZER INC. | $24.75 | 1 | $0 (2023) |
| Alkermes, Inc. | $16.19 | 1 | $0 (2023) |
| Novo Nordisk Inc | $13.29 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $21.47 | 1 | Boehringer Ingelheim Pharmaceuticals, Inc. ($21.47) |
| 2023 | $217.39 | 13 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($71.59) |
| 2022 | $12.46 | 1 | GlaxoSmithKline, LLC. ($12.46) |
All Payment Transactions
15 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/14/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $21.47 | General |
| 11/06/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.02 | General |
| Category: RESPIRATORY | ||||||
| 07/18/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY, SHINGRIX | Food and Beverage | In-kind items and services | $18.18 | General |
| Category: RESPIRATORY | ||||||
| 06/29/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.38 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/07/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $17.79 | General |
| Category: Gastroenterology | ||||||
| 05/10/2023 | Novo Nordisk Inc | Saxenda (Drug), Wegovy | Food and Beverage | In-kind items and services | $13.29 | General |
| Category: Obesity | ||||||
| 05/01/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $20.38 | General |
| Category: Gastroenterology | ||||||
| 04/27/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.65 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/18/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $24.75 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 03/30/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $13.49 | General |
| Category: DIABETES | ||||||
| 03/15/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.85 | General |
| Category: RESPIRATORY | ||||||
| 03/08/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $19.08 | General |
| Category: Gastroenterology | ||||||
| 01/27/2023 | Alkermes, Inc. | Vivitrol (Drug) | Food and Beverage | In-kind items and services | $16.19 | General |
| Category: CNS | ||||||
| 01/25/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.34 | General |
| Category: Gastroenterology | ||||||
| 04/14/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $12.46 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 11 | 373 | 544 | $43,798 | $13,724 |
| 2021 | 16 | 632 | 920 | $65,974 | $22,276 |
| 2020 | 13 | 569 | 700 | $77,768 | $25,125 |
Total Patients
1,574
Total Services
2,164
Medicare Billing
$61,125
Procedure Codes
40
All Medicare Procedures & Services
40 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 90 | 108 | $14,738 | $4,649 | 31.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 46 | 48 | $9,736 | $3,634 | 37.3% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2022 | 50 | 52 | $7,852 | $2,084 | 26.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 12 | 12 | $3,718 | $1,284 | 34.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 14 | 14 | $2,831 | $949.03 | 33.5% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2022 | 17 | 34 | $1,059 | $535.28 | 50.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 39 | 48 | $2,235 | $293.35 | 13.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 45 | 48 | $288.00 | $142.29 | 49.4% |
| 81003 | Automated urinalysis test | Office | 2022 | 25 | 31 | $465.00 | $68.93 | 14.8% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2022 | 22 | 96 | $346.56 | $64.80 | 18.7% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2022 | 13 | 53 | $530.00 | $19.02 | 3.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 132 | 152 | $20,742 | $7,404 | 35.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 70 | 79 | $16,024 | $5,762 | 36.0% |
| 87426 | Elisa detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2021 | 47 | 49 | $7,399 | $2,216 | 30.0% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 29 | 29 | $5,864 | $2,169 | 37.0% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 13 | 13 | $4,027 | $1,488 | 36.9% |
| 87804 | Detection test by immunoassay for influenza virus | Office | 2021 | 21 | 42 | $1,309 | $695.10 | 53.1% |
| 87811 | Sars-cov-2 covid19 w/optic | Office | 2021 | 17 | 17 | $2,567 | $662.08 | 25.8% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 48 | 67 | $3,120 | $474.92 | 15.2% |
| 71046 | X-ray of chest, 2 views | Office | 2021 | 21 | 21 | $1,074 | $362.76 | 33.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 97 | 111 | $666.00 | $333.00 | 50.0% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2021 | 27 | 32 | $677.12 | $248.64 | 36.7% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2021 | 22 | 23 | $539.58 | $242.88 | 45.0% |
| 81003 | Automated urinalysis test | Office | 2021 | 39 | 44 | $660.00 | $97.37 | 14.8% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2021 | 20 | 90 | $324.90 | $79.55 | 24.5% |
About Candis Adams, APRN
Candis Adams, APRN is a Family healthcare provider based in Wynne, Arkansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/27/2017. The National Provider Identifier (NPI) number assigned to this provider is 1932623360.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Candis Adams, APRN has received a total of $251.32 in payments from pharmaceutical and medical device companies, with $21.47 received in 2024. These payments were reported across 15 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($251.32).
As a Medicare-enrolled provider, Adams has provided services to 1,574 Medicare beneficiaries, totaling 2,164 services with total Medicare billing of $61,125. Data is available for 3 years (2020–2022), covering 40 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location Wynne, AR
- Active Since 07/27/2017
- Last Updated 12/06/2022
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1932623360
Products in Payments
- XIFAXAN (Drug) $71.59
- TRELEGY ELLIPTA (Drug) $63.51
- FARXIGA (Drug) $27.03
- ELIQUIS (Drug) $24.75
- Vivitrol (Drug) $16.19
- JARDIANCE (Drug) $13.49
- Saxenda (Drug) $13.29
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Wynne
Ashley Bagwell, Aprn, APRN
Family — Payments: $2,020
Family $2,020
Jodi Renigar, Aprn, Fnp-Bc, APRN, FNP-BC
Family — Payments: $971.26
Family $971.26
Mrs. Denise Purnell, Np, NP
Family — Payments: $919.83
Family $919.83
Ashley Duncan, Aprn, APRN
Family — Payments: $732.34
Family $732.34
Allison Doss
Family — Payments: $598.68
Family $598.68
Heather Hamm
Family — Payments: $558.32
Family $558.32